MX2019011517A - Proceso para producir analogos de anillo de arilomicina. - Google Patents
Proceso para producir analogos de anillo de arilomicina.Info
- Publication number
- MX2019011517A MX2019011517A MX2019011517A MX2019011517A MX2019011517A MX 2019011517 A MX2019011517 A MX 2019011517A MX 2019011517 A MX2019011517 A MX 2019011517A MX 2019011517 A MX2019011517 A MX 2019011517A MX 2019011517 A MX2019011517 A MX 2019011517A
- Authority
- MX
- Mexico
- Prior art keywords
- making
- arylomyin
- ring analogs
- ring
- analogs
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D245/00—Heterocyclic compounds containing rings of more than seven members having two nitrogen atoms as the only ring hetero atoms
- C07D245/02—Heterocyclic compounds containing rings of more than seven members having two nitrogen atoms as the only ring hetero atoms not condensed with other rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/06—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length using protecting groups or activating agents
- C07K1/061—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length using protecting groups or activating agents using protecting groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/64—Cyclic peptides containing only normal peptide links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Analytical Chemistry (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
Métodos para hacer un anillo de arilomicina de la fórmula t (ver fórmula) o sales o solvatos del mismo, en donde R, R1, R2, R3, R4, R5, R6, R7, R8, R9, R5, R10 y Pg1 son como se definen en la presente.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201762477268P | 2017-03-27 | 2017-03-27 | |
PCT/US2018/024351 WO2018183198A1 (en) | 2017-03-27 | 2018-03-26 | Process for making arylomyin ring analogs |
Publications (1)
Publication Number | Publication Date |
---|---|
MX2019011517A true MX2019011517A (es) | 2019-11-18 |
Family
ID=61913697
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2019011517A MX2019011517A (es) | 2017-03-27 | 2018-03-26 | Proceso para producir analogos de anillo de arilomicina. |
Country Status (16)
Country | Link |
---|---|
US (2) | US11192924B2 (es) |
EP (1) | EP3601240B1 (es) |
JP (1) | JP7041687B2 (es) |
KR (1) | KR102589474B1 (es) |
CN (2) | CN117777229A (es) |
AU (2) | AU2018243724B2 (es) |
BR (1) | BR112019020112A2 (es) |
CA (1) | CA3057997A1 (es) |
ES (1) | ES2892173T3 (es) |
HR (1) | HRP20211495T1 (es) |
IL (1) | IL269532B (es) |
MX (1) | MX2019011517A (es) |
PL (1) | PL3601240T3 (es) |
SG (1) | SG11201908932SA (es) |
SI (1) | SI3601240T1 (es) |
WO (1) | WO2018183198A1 (es) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP6873993B2 (ja) | 2015-11-20 | 2021-05-19 | アールキューエックス ファーマシューティカルズ,インク. | 大環状広域抗生物質 |
WO2018149419A1 (en) | 2017-02-15 | 2018-08-23 | Rqx Pharmaceuticals, Inc. | Macrocyclic broad spectrum antibiotics |
HRP20231497T1 (hr) * | 2019-05-28 | 2024-03-01 | F. Hoffmann-La Roche Ag | Makrociklični antibiotici širokog spektra |
-
2018
- 2018-03-26 AU AU2018243724A patent/AU2018243724B2/en active Active
- 2018-03-26 CN CN202311833909.0A patent/CN117777229A/zh active Pending
- 2018-03-26 JP JP2019553110A patent/JP7041687B2/ja active Active
- 2018-03-26 ES ES18716874T patent/ES2892173T3/es active Active
- 2018-03-26 HR HRP20211495TT patent/HRP20211495T1/hr unknown
- 2018-03-26 EP EP18716874.5A patent/EP3601240B1/en active Active
- 2018-03-26 CA CA3057997A patent/CA3057997A1/en active Pending
- 2018-03-26 CN CN201880020965.3A patent/CN110475766B/zh active Active
- 2018-03-26 WO PCT/US2018/024351 patent/WO2018183198A1/en unknown
- 2018-03-26 SG SG11201908932S patent/SG11201908932SA/en unknown
- 2018-03-26 MX MX2019011517A patent/MX2019011517A/es unknown
- 2018-03-26 KR KR1020197031578A patent/KR102589474B1/ko active IP Right Grant
- 2018-03-26 SI SI201830418T patent/SI3601240T1/sl unknown
- 2018-03-26 BR BR112019020112A patent/BR112019020112A2/pt active Search and Examination
- 2018-03-26 PL PL18716874T patent/PL3601240T3/pl unknown
-
2019
- 2019-09-23 IL IL269532A patent/IL269532B/en unknown
- 2019-09-24 US US16/581,116 patent/US11192924B2/en active Active
-
2021
- 2021-11-02 US US17/517,103 patent/US11702452B2/en active Active
-
2022
- 2022-08-16 AU AU2022218486A patent/AU2022218486B2/en active Active
Also Published As
Publication number | Publication date |
---|---|
SI3601240T1 (sl) | 2021-11-30 |
AU2022218486A1 (en) | 2022-09-08 |
CN110475766A (zh) | 2019-11-19 |
US11192924B2 (en) | 2021-12-07 |
HRP20211495T1 (hr) | 2021-12-24 |
CN117777229A (zh) | 2024-03-29 |
AU2018243724A1 (en) | 2019-10-03 |
IL269532A (en) | 2019-11-28 |
PL3601240T3 (pl) | 2021-12-20 |
ES2892173T3 (es) | 2022-02-02 |
US11702452B2 (en) | 2023-07-18 |
AU2018243724B2 (en) | 2022-07-28 |
EP3601240A1 (en) | 2020-02-05 |
SG11201908932SA (en) | 2019-10-30 |
WO2018183198A1 (en) | 2018-10-04 |
CA3057997A1 (en) | 2018-10-04 |
US20200255476A1 (en) | 2020-08-13 |
KR20190133033A (ko) | 2019-11-29 |
AU2022218486B2 (en) | 2023-09-28 |
KR102589474B1 (ko) | 2023-10-16 |
US20220056078A1 (en) | 2022-02-24 |
IL269532B (en) | 2021-12-01 |
BR112019020112A2 (pt) | 2020-05-05 |
CN110475766B (zh) | 2023-12-29 |
EP3601240B1 (en) | 2021-08-04 |
JP7041687B2 (ja) | 2022-03-24 |
JP2020512353A (ja) | 2020-04-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PH12021550167A1 (en) | Heterobicyclic compounds for inhibiting the activity of shp2 | |
PH12019550041A1 (en) | Compounds and methods for ido and tdo modulation, and indications therefor | |
MX2021002978A (es) | Lactamas biciclicas y metodos de uso de las mismas. | |
PH12017502090A1 (en) | Heterocyclic amides as kinase inhibitors | |
PH12017500658B1 (en) | Spirodiamine derivatives as aldosterone synthase inhibitors | |
MX2020005622A (es) | Compuestos de indol sustituidos con arilo y heteroarilo. | |
MX2016011992A (es) | Derivados de piperidina-diona. | |
TW201613872A (en) | IRAK4 inhibiting agents | |
PH12016501440A1 (en) | Novel heterocyclic compounds | |
UY36122A (es) | ?derivados de pirrolidina-2,5-diona, composiciones farmacéuticas y métodos para usar como inhibidores ido1? | |
PH12019500664A1 (en) | New isoxazolyl ether derivatives as gaba a alpha5 pam | |
PH12020500655A1 (en) | Compounds | |
PH12018500268A1 (en) | 2-amino-3-fluoro-3-(fluoromethyl)-6-methyl-6-phenyl-3,4,5,6-tetrahydropyridins as bace1 inhibitors | |
MX2015010775A (es) | Benzoxazoles sustituidos y metodos para usarlos. | |
MX2016008499A (es) | Derivados de arilsultamo como moduladores del receptor huerfano relacionado con el receptor de retinoide (rorc). | |
PH12020500105A1 (en) | Bicyclic ketone compounds and methods of use thereof | |
MX2015001099A (es) | Nuevos derivados biciclicos de piridina. | |
MX2019011517A (es) | Proceso para producir analogos de anillo de arilomicina. | |
MX2021001565A (es) | Inhibidores tipo indol y azaindol de enzimas peptidil arginina deiminasas (pad). | |
MX2022000550A (es) | Imidazopirimidinas como inhibidores de eed y uso de estas. | |
PH12016501613A1 (en) | Pyrazines modulators of gpr6 | |
MX2015016400A (es) | Nuevos compuestos de 3,4-dihidro-2h-isoquinolin-1-ona y 2,3-dihidro-isoindol-1-ona. | |
PH12018500668A1 (en) | Therapeutic compounds and methods of use thereof | |
MX2019002017A (es) | Derivados de sofosbuvir para el tratamiento de la hepatitis c. | |
SG10201810263QA (en) | Nampt inhibitors and methods |